BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14767474)

  • 1. Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes.
    Neben K; Tews B; Wrobel G; Hahn M; Kokocinski F; Giesecke C; Krause U; Ho AD; Krämer A; Lichter P
    Oncogene; 2004 Mar; 23(13):2379-84. PubMed ID: 14767474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrosome aberrations in hematological malignancies.
    Krämer A; Neben K; Ho AD
    Cell Biol Int; 2005 May; 29(5):375-83. PubMed ID: 15996491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.
    Iovino F; Lentini L; Amato A; Di Leonardo A
    Mol Cancer; 2006 Sep; 5():38. PubMed ID: 16987420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrosome replication, genomic instability and cancer.
    Krämer A; Neben K; Ho AD
    Leukemia; 2002 May; 16(5):767-75. PubMed ID: 11986936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression.
    Koutsami MK; Tsantoulis PK; Kouloukoussa M; Apostolopoulou K; Pateras IS; Spartinou Z; Drougou A; Evangelou K; Kittas C; Bartkova J; Bartek J; Gorgoulis VG
    J Pathol; 2006 Aug; 209(4):512-21. PubMed ID: 16739112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrosome amplification and aneuploidy in bone marrow failure patients.
    Kearns WG; Yamaguchi H; Young NS; Liu JM
    Genes Chromosomes Cancer; 2004 Aug; 40(4):329-33. PubMed ID: 15188456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile.
    Neben K; Giesecke C; Schweizer S; Ho AD; Krämer A
    Blood; 2003 Jan; 101(1):289-91. PubMed ID: 12393441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortalin controls centrosome duplication via modulating centrosomal localization of p53.
    Ma Z; Izumi H; Kanai M; Kabuyama Y; Ahn NG; Fukasawa K
    Oncogene; 2006 Aug; 25(39):5377-90. PubMed ID: 16619038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrosome control of the cell cycle.
    Doxsey S; Zimmerman W; Mikule K
    Trends Cell Biol; 2005 Jun; 15(6):303-11. PubMed ID: 15953548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnosis of acute myeloid leukaemia enhanced by using DNA microarrays].
    Löwenberg B; Delwel HR; Valk PJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):623-5. PubMed ID: 15813428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
    Lindvall C; Furge K; Björkholm M; Guo X; Haab B; Blennow E; Nordenskjöld M; Teh BT
    Haematologica; 2004 Sep; 89(9):1072-81. PubMed ID: 15377468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the biology of acute myeloid leukemia and their impact on treatment.
    Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
    Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrosome aberrations and cancer.
    Krämer A; Ho AD
    Onkologie; 2001 Dec; 24(6):538-44. PubMed ID: 11799308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.
    Ekberg J; Holm C; Jalili S; Richter J; Anagnostaki L; Landberg G; Persson JL
    Eur J Haematol; 2005 Aug; 75(2):106-15. PubMed ID: 16004607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.
    Trachana V; van Wely KH; Guerrero AA; Fütterer A; Martínez-A C
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2691-6. PubMed ID: 17299043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrations.
    Ottaggio L; Zunino A; Maric I; Grozio A; Rossi E; Spriano M; Viaggi S
    Hematol Oncol; 2008 Mar; 26(1):39-42. PubMed ID: 18050363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of cell cycle control genes in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib.
    Fabarius A; Giehl M; Rebacz B; Krämer A; Frank O; Haferlach C; Duesberg P; Hehlmann R; Seifarth W; Hochhaus A
    Haematologica; 2008 Aug; 93(8):1145-54. PubMed ID: 18519516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
    Downing JR
    Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.